Randomized trial of daily high-dose vitamin D(3) in patients with RRMS receiving subcutaneous interferon β-1a

OBJECTIVE: In the phase II, randomized, double-blind, placebo-controlled Supplementation of Vigantol Oil versus Placebo Add-on in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS) Receiving Rebif Treatment (SOLAR) study (NCT01285401), we assessed the efficacy and safety of add-on vitamin D...

Descripción completa

Detalles Bibliográficos
Autores principales: Hupperts, Raymond, Smolders, Joost, Vieth, Reinhold, Holmøy, Trygve, Marhardt, Kurt, Schluep, Myriam, Killestein, Joep, Barkhof, Frederik, Beelke, Manolo, Grimaldi, Luigi M.E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946471/
https://www.ncbi.nlm.nih.gov/pubmed/31594857
http://dx.doi.org/10.1212/WNL.0000000000008445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946471/
https://www.ncbi.nlm.nih.gov/pubmed/31594857
http://dx.doi.org/10.1212/WNL.0000000000008445

Ejemplares similares